Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Jman who wrote (18278)	1/28/1999 6:32:00 PM
From: EyeDrMike	Read Replies (4) \| Respond to of 23519

They have no domestic partner, hence no real sales or profits in the US for this quarter. In addition, Astra already bought last year, so no Astra money this quarter. How big will the loss be next EPS? and does VVUS have enough operating cash to pay bills. From what i've heard, VVUS has told plant employees they "hope" to increase production levels in a few months. Not the most robust indication for the future.

To: Jman who wrote (18278)	1/28/1999 6:37:00 PM
From: RealMuLan	Read Replies (1) \| Respond to of 23519

Jman: you're welcome. The problem is that the company'd better guided down the First Call estimates, which is now at 13 cents. Everybody will be better off to start from low point, and then give some surprise, like this quarter. Otherwise, in this kind small-cap-company-being-killed market, a company like VVUS cannot survive. Look what happened to Administaff. They missed 4 cents in earning, got 27 cents vs. 31 estimates. The stock went down >50% in just one day. Vast majority of the stock market gain went to a small handful, 30-60, big companies.